We help leading pharmaceutical and biotech companies navigate and resolve contentious issues arising out of their life sciences contracts, especially those involving highly technical, IP-rich subject matter.
Our team has in-depth knowledge of the drug development life cycle from bench-scale production through to trial phases, regulatory approval, manufacture scale-up and commercialisation. This informed expertise means we are able to resolve a wide spectrum of disputes such as those relating to licensing IP and know-how, technical/quality agreements, research collaboration contracts, API manufacturing, development services, supply and distribution.
We also advise on product liability and misuse of confidential information matters related to medicinal drugs and medical devices.
Our clients trust us to assess and manage complex disputes through to resolution on a spread of issues including breach of contract, wrongful termination, royalty rate assessments, trial phases, GMP and regulatory compliance, product liability and misuse of confidential information. Where needed, we bring in expertise from our specialist life sciences regulatory, patent litigation and commercial contracts teams.
If unavoidable, we vigorously deploy our strong experience in litigation, arbitration and other forms of ADR such as mediation, expert determination and judicial review to protect our clients’ interests and enforce their rights.